This research examines CD36, a protein found on the surface of various cells including immune cells, fat cells, and platelets. Scientists have discovered that CD36 plays a crucial role in the development of atherosclerosis - the process where arteries become clogged and hardened, leading to heart disease and stroke.
The key finding is that CD36 acts like a receptor that allows immune cells called macrophages to absorb oxidized LDL cholesterol (the "bad" cholesterol that has become damaged). When macrophages take up too much of this damaged cholesterol through CD36, they transform into "foam cells" - bloated cells that get stuck in artery walls and form the foundation of atherosclerotic plaques. Additionally, CD36 prevents these immune cells from moving away from trouble spots, essentially trapping them in developing plaques where they contribute to inflammation and artery damage.
Laboratory studies show that when CD36 is blocked or removed, atherosclerotic plaque formation is significantly reduced. The protein also affects platelets, making them more likely to form dangerous blood clots when plaques rupture. This research suggests that CD36 could be an important target for preventing or treating heart disease.
For patients focused on metabolic health and longevity, this research highlights how cholesterol oxidation and immune system dysfunction work together to damage arteries. At VALIA Health, this understanding helps inform personalized strategies to reduce oxidative stress, optimize cholesterol profiles, and support healthy immune function as part of comprehensive cardiovascular protection.
Disclaimer: This summary is AI-generated for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making health decisions.